MCK · NYSE
McKesson Corporation
$1,000.77 -8.54 (-0.85%)
Company overview
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices, as well as consulting, outsourcing, technological, and other services, and sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Exchange
- NYSE
- Market cap
- $117B
- Employees
- 44,000
- Headquarters
- Irving, TX
- Website
- mckesson.com
- CEO
- Brian S. Tyler
- Listed
- November 10, 1994
- P/E
- 25.90
- Dividend yield
- 0.38%
Company financials
- Revenue
- $403B
- Gross profit
- $14.6B
- Operating income
- $6.4B
- EBITDA
- $7.2B
- Net income
- $4.8B
- EPS
- $38.64
- Total assets
- $82.3B
- Total debt
- $8.6B
- Gross margin
- 3.61%
- Net margin
- 1.18%
- Earnings yield
- 3.86%
No annual geographic segmentation.
Showing FY 2026
MCK
1D
NYSE
O1,025.62H1,025.62L1,006.07C1,012.34-3.16 (-0.31%)Vol629.49K